View Cart  

U.S. FDA Commissioner: Transparency Needed Among International Regulators

PHILADELPHIA — The U.S. Food and Drug Administration (FDA) and international regulators must establish a much more collaborative framework in order to ensure the safety of the world’s drug supply chains, FDA Commissioner Margaret Hamburg says.

To View This Article:


Subscribe To International Pharmaceutical Regulatory Monitor

Buy This Article Now

Add this article to your cart for $40.00